Navigation Links
China Biologic to Host Earnings Conference Call on November 8, 2011 at 8:00 a.m. EST (NY)
Date:11/4/2011

BEIJING, Nov. 4, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in China, today announced that it will host an earnings conference call covering its third quarter 2011 financial results on Tuesday, November 8, 2011 at 8:00 a.m. EST (New York), which is also 9:00 p.m. in China on the same day.

Hosting the call will be Mr. Colin Zhao, Chief Executive Officer of the Company, and Mr. Tristan Kuo, the Company's Chief Financial Officer.The dial-in details for the live conference call are as follows:U.S. toll-free number:

1 866 549 1292U.K. toll-free number:

0 800 279 7818Mainland China toll-free number:

800 876 8626Hong Kong local access number:

3005 2050International toll number:

+852 3005 2050Conference passcode:

674477#A telephone replay will be available after the conclusion of the conference call for thirty days, until December 7, 2011.The dial-in details for the replay are as follows:U.S. toll-free number:

1 866 753 0743U.K. toll-free number:

0 808 234 7126Mainland China number:

800 876 8594Hong Kong number:

3005 2020International toll number:

+852 3005 2020 Conference ID:

138012# About China Biologic Products, Inc.China Biologic Products, Inc., through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. and Guizhou Taibang Biological Co., and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is one of the leading plasma-based biopharmaceutical companies in China. The Company is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies and are used for the prevention and treatment of various diseas
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Life Technologies Launches 3500 Dx Series Genetic Analyzers for In Vitro Diagnostic Use in China
2. China Biologic Named to Asias "200 Best Under a Billion" by Forbes Asia
3. United States Holds Global Lead in Breast Cancer Research Publications as China Surges to Forefront, According to Report
4. China Botanic Appoints Zack Zibing Pan as an Independent Director and Chairman of its Audit Committee
5. China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 19, 2011
6. Industrial Biotechnology China News 1109 - Annual Subscription
7. ThermoGenesis Announces Acceptance of AXP® Submission by Regulatory Body in China
8. China Cord Blood Corporation Files Its Annual Report on Form 20-F
9. China Botanic Pharmaceutical Reports Third-Quarter Fiscal Year 2011 Results
10. Industrial Biotechnology China News 1108
11. China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... Denmark , July 30, 2015 ... biotechnology company that applies its innovative TransCon technology ... positive top-line results from a six-month Phase 2 ... once-weekly TransCon Growth Hormone in 53 treatment-naïve, pre-pubertal ... "We are extremely pleased with the top-line ...
(Date:7/30/2015)... Pa. , July 30, 2015  Discovery ... that it has received the second $1.0M tranche ... Innovation Research (SBIR) grant valued at up to ... company,s aerosolized KL4 surfactant as a potential medical ... injury.  Discovery Labs was awarded an initial $1.0 ...
(Date:7/30/2015)... ... July 30, 2015 , ... GEA's Pony™ ... for continuous operation up to 1500 bar. The sanitary design gauge of the ... toxic contamination. , The Pony™ NS2006L homogenizer is an ideal solution for the ...
(Date:7/29/2015)... 30, 2015 Sanofi, un ... ses résultats pour le premier semestre 2015. Le ... résultats. Visionner l,interview vidéo et lire ... Au sommaire de l,interview :  ... de croissance - Diabète ...
Breaking Biology Technology:Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2
... Ala. , May 12 Atherotech Inc. will exhibit its ... Scientific Sessions 2010. The meeting takes place May 13-16 at ... , , ... lipid test that routinely reports directly measured LDL-C, which is included in ...
... ,, RESEARCH TRIANGLE PARK, N.C. , May 12 ... Research Clinical Trials and Statistics Unit, is running the Intergroup Exemestane Study ... women with early breast cancer and a median follow-up period of 91 ... the data from multiple centers. , ...
... Indiana Seed Fund, Indiana ,s only targeted life sciences seed ... Indianapolis -based biotechnology start-up company focused on the development of ... , , , ... 5 million Americans suffer from Alzheimer,s disease (AD), a number that ...
Cached Biology Technology:Atherotech Emphasizes Predictive Value of VAP(R) Cholesterol Test at National Lipid Association Meeting 2Atherotech Emphasizes Predictive Value of VAP(R) Cholesterol Test at National Lipid Association Meeting 3Max Neeman International Signs Agreement for Data Management/EDC of Large Phase IV Trials from Multiple Sites 2BioCrossroads Invests in Indianapolis Biotech Company Developing Treatments for Alzheimer's Disease 2BioCrossroads Invests in Indianapolis Biotech Company Developing Treatments for Alzheimer's Disease 3BioCrossroads Invests in Indianapolis Biotech Company Developing Treatments for Alzheimer's Disease 4
(Date:7/27/2015)... ANGELES , July 27, 2015   ... evidence- and experience-based clinical improvement solutions, today announced ... solution is now available on Android smartphones and ... inpatient and post-care organizations can use ZynxCarebook to ... same patient,s condition, streamline care transitions to other ...
(Date:7/23/2015)... DUBLIN , July 23, 2015 ... the addition of the "Global Outlook of ... their offering. The global biometrics ... both public and commercial applications owing to the ... will witness a transformation that enhances the growth ...
(Date:7/21/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market and ... it has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology ... but also the user using unique personal identifiers ...
Breaking Biology News(10 mins):Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4
... regions of the human genome that regulate gene expression may ... of human diseases, according to researchers at Dukes Institute for ... in our bodies is packaged, or tightly structured, said Gregory ... the senior investigators on this study. Our goal was to ...
... CAMBRIDGE, Mass.--MIT and New York University researchers have identified ... that could be exploited to produce new antibiotics. ... critical part of Bacillus anthracis,s defense against the immune ... bacteria that cannot produce NO succumb to the immune ...
... some of which are so tiny that 30 can fit across ... they are among the key organisms taking the greenhouse gas carbon ... are so heavy that when they die in the oceans they ... of the surface waters and locking it into sediments below. ...
Cached Biology News:Search for the 'on' switches may reveal genetic role in development and disease 2Team IDs weakness in anthrax bacteria 2Ecologists, material scientists pursue genetics of diatom's elegant, etched casing 2Ecologists, material scientists pursue genetics of diatom's elegant, etched casing 3
Request Info...
Porcine TNF-alpha/TNFSF1A ELISpot Development Module...
Request Info...
Services include subcloning into an expression vector. Tagged protein will be expressed in small scale for testing yield and solubility and then in 1L culture for large scale affinity purification. E...
Biology Products: